Image

Duke Spine Outcome Study (DSOS)

Recruiting
18 - 85 years of age
Both
Phase N/A

Powered by AI

Overview

The primary goal of this registry is to increase the knowledge about spine tumors and other spine disorders to guide appropriate management strategies for the future. This registry will include the review of medical records, data collection for health related quality of life questionnaires, and collected tissues and samples.

The study will require obtaining spinal lesions (tumor, etc.), blood, and bone marrow samples (from non-lesional bone) from selected patients, which will be collected during your surgery.

Eligibility

Inclusion Criteria:

  • Age between 18 and 85 years.
  • Able to read and write local language at an elementary level.
  • Diagnosis of primary or metastatic tumor of the spine ); or
  • Infection of the spine; or
  • Instability of the spine; or
  • Injury of the spine.
  • Accessibility for treatment and follow up.
  • Patient consent obtained according to Duke institutional policy.

Inclusion criteria for spine surgery (control population for bone marrow specimens)

  • Age between 18 and 85 years.
  • Spine surgery to be performed at Duke University Medical Center (DUMC) under the auspices of the neurosurgery program.
  • No concurrent cancer diagnosis.
  • Accessibility for treatment and follow up.
  • Patient consent obtained according to Duke institutional policy.

Exclusion Criteria:

  • History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening
  • Is a prisoner.
  • A disease or condition that would, in opinion of the investigator, preclude accurate evaluation

    (e.g. significant psychiatric disease), or that would impair the ability of the patient to receive protocol treatment or comply with protocol.

  • Pregnant or breast feeding during the study period (women of child-bearing potential will require a negative serum pregnancy test within 30 days of enrollment).
  • Active infection, or fever of unknown origin.
  • Inflammatory bowel disease.
  • Systemic lupus erythematosus.
  • Rheumatoid arthritis, or other autoimmune disease.
  • History of or active hematologic or bone marrow diseases, including but not limited to diagnosed lymphomas, leukemias, sickle cell or other anemias not associated with their current condition.
  • Polycythemia vera.
  • Known or suspected immunodeficiency or Human Immunodeficiency Virus (HIV).
  • Hematocrit < 24% pre-operatively.

Study details

Spinal Tumor, Spinal Disorder

NCT04217525

Duke University

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.